2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 25.345 | 26.940 | 28.172 | 39.486 | 47.017 | 53.529 | 70.812 | 79.027 | 77.457 | 121.151 |
Total Income - EUR | 25.345 | 26.940 | 28.172 | 39.486 | 47.017 | 53.529 | 70.812 | 79.027 | 77.457 | 121.151 |
Total Expenses - EUR | 6.183 | 9.829 | 7.503 | 6.491 | 8.723 | 51.504 | 11.547 | 9.257 | 13.554 | 54.417 |
Gross Profit/Loss - EUR | 19.162 | 17.112 | 20.669 | 32.994 | 38.294 | 2.025 | 59.266 | 69.770 | 63.904 | 66.734 |
Net Profit/Loss - EUR | 18.402 | 16.304 | 19.824 | 31.810 | 36.884 | 419 | 57.217 | 67.446 | 62.166 | 65.704 |
Employees | 2 | 2 | 1 | 1 | 0 | 2 | 2 | 2 | 1 | 0 |
Check the financial reports for the company - Asmedi Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 21.106 | 21.282 | 21.065 | 20.709 | 39.752 | 38.982 | 38.243 | 37.395 | 37.511 | 37.191 |
Current Assets | 18.009 | 26.391 | 44.115 | 55.690 | 72.788 | 71.806 | 110.038 | 71.728 | 66.369 | 167.716 |
Inventories | 513 | 1.269 | 32.461 | 31.912 | 49.446 | 49.141 | 48.210 | 47.141 | 47.287 | 53.770 |
Receivables | 17.496 | 25.123 | 11.654 | 23.779 | 23.342 | 22.664 | 23.606 | 0 | 19.082 | 31.131 |
Cash | 0 | 0 | 0 | 0 | 0 | 0 | 38.222 | 24.587 | 0 | 82.815 |
Shareholders Funds | 39.115 | 45.824 | 65.180 | 76.399 | 111.881 | 110.133 | 146.326 | 108.820 | 102.654 | 168.047 |
Social Capital | 245 | 247 | 245 | 241 | 236 | 232 | 227 | 222 | 223 | 222 |
Debts | 0 | 1.850 | 0 | 0 | 660 | 655 | 1.956 | 303 | 1.226 | 36.860 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "8621 - 8621" | |||||||||
CAEN Financial Year |
8621
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Asmedi Srl